ID: ALA4537653

Max Phase: Preclinical

Molecular Formula: C24H22N2O3

Molecular Weight: 386.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1cc(O)c(-c2ccc(C3(CN)CC3)cc2)c2c1[nH]c(=O)c1c(O)cccc12

Standard InChI:  InChI=1S/C24H22N2O3/c1-13-11-18(28)19(14-5-7-15(8-6-14)24(12-25)9-10-24)21-16-3-2-4-17(27)20(16)23(29)26-22(13)21/h2-8,11,27-28H,9-10,12,25H2,1H3,(H,26,29)

Standard InChI Key:  CHSUNMGWJYCGOA-UHFFFAOYSA-N

Associated Targets(Human)

PDZ-binding kinase 995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-15 51914 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 386.45Molecular Weight (Monoisotopic): 386.1630AlogP: 4.06#Rotatable Bonds: 3
Polar Surface Area: 99.34Molecular Species: BASEHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.73CX Basic pKa: 9.65CX LogP: 2.97CX LogD: 2.69
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: 0.33

References

1. Hu QF, Gao TT, Shi YJ, Lei Q, Liu ZH, Feng Q, Chen ZJ, Yu LT..  (2019)  Design, synthesis and biological evaluation of novel 1-phenyl phenanthridin-6(5H)-one derivatives as anti-tumor agents targeting TOPK.,  162  [PMID:30453248] [10.1016/j.ejmech.2018.11.007]

Source